Uveal melanoma: Prognostication

Monographs in Clinical Cytology

Volumn 21, Issue , 2012, Pages 55-60

  Turell, Mary E ^a   Tubbs, Raymond R ^a   Biscotti, Charles V ^a   Singh, Arun D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLUSTER ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; KARYOTYPING; MELANOMA; METHODOLOGY; MICROARRAY ANALYSIS; NEEDLE BIOPSY; PATHOLOGY; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; UVEA MELANOMA; UVEA TUMOR;

BIOPSY, FINE-NEEDLE; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MELANOMA; MICROARRAY ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; SURVIVAL RATE; UVEAL NEOPLASMS;

EID: 84863417675     PISSN: 00770809     EISSN: 16623827     Source Type: Book Series    
DOI: 10.1159/000331035     Document Type: Article

References (38)

1. Kujala E, Makitie T, Kivela T: Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003;44:4651-4659. (Pubitemid 37315273)
2. Singh AD: Uveal melanoma: implications of tumor doubling time. Ophthalmology 2001;108:829-831.
3. Eskelin S, Pyrhonen S, Summanen P, Hahka-Kemppinen M, Kivela T: Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology 2000;107:1443-1449.
4. Augsburger JJ, Corrêa ZM, Shaikh AH: Effectiveness of treatments for metastatic uveal melanoma. Am J Ophthalmol 2009;148:119-127.
5. Callender GR: Malignant melanotic tumors of the eye: a study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol 1993;36:131-142.
6. McLean IW, Zimmerman LE, Evans RM: Reappraisal of Callender's spindle A type of malignant melanoma of choroid and ciliary body. Am J Ophthalmol 1978;86:557-564. (Pubitemid 8397387)
7. McLean IW, Foster WD, Zimmerman LE: Prognostic factors in small malignant melanomas of choroid and ciliary body. Arch Ophthalmol 1977;95:48-58. (Pubitemid 8258614)
8. Shammas HF, Blodi FC: Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol 1977;95:63-69. (Pubitemid 8258615)
9. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, et al: Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999;155:739-752. (Pubitemid 29426820)
10. De la Cruz PO, Specht CS, McLean IW: Lymphocytic infiltration in uveal malignant melanoma. Cancer 1990;65:112-115. (Pubitemid 20026820)
11. Horsthemke B, Prescher G, Bornfeld N, et al: Loss of chromosome 3 alleles and multiplication of chromosome 8 alleles in uveal melanoma. Genes Chromosomes Cancer 1992;4:217-221.
12. Sisley K, Rennie IG, Cottam DW, et al: Cytogenetic findings in six posterior uveal melanomas: involvement of chromosomes 3, 6, and 8. Genes Chromosomes Cancer 1990;2:205-209. (Pubitemid 20369595)
13. Sisley K, Cottam DW, Rennie IG, et al: Nonrandom abnormalities of chromosomes 3, 6, and 8 associated with posterior uveal melanoma. Genes Chromosomes Cancer 1992;5:197-200.
14. Onken MD, Ehlers JP, Worley LA, Makita J, Yokota Y, et al: Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res 2006;66:4602-4609.
15. Singh AD, Sisley K, Wackernagel W: Genetics of uveal melanoma; in Albert DM, Miller JW, Azar DT, Blodi BA (eds): Albert and Jakobiec's Principles and Practice of Ophthalmology, ed 3. Philadelphia, Saunders, chapt 355.
16. Prescher G, Bornfeld N, Horsthemke B, Becher R: Chromosomal aberrations defining uveal melanoma of poor prognosis. Lancet 1992;339:691-692.
17. Prescher G, Bornfeld N, Hirche H, et al: Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996;347:1222-1225. (Pubitemid 26131850)
18. Sisley K, Rennie IG, Andrew M: Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer 1997;19:22-28. (Pubitemid 27193716)
19. Horsman DE, Sroka H, Rootman J, White VA: Monosomy 3 and isochromosome 8q in a uveal melanoma. Cancer Genet Cytogenet 1990;45:249-253. (Pubitemid 20129149)
20. Prescher G, Bornfeld N, Becher R: Nonrandom chromosomal abnormalities in primary uveal melanoma. J Natl Cancer Inst 1990;82:1765-1769.
21. Aalto Y, Eriksson L, Seregard S, Larsson O, Knuutila S: Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci 2001;42:313-317. (Pubitemid 32121456)
22. Patel KA, Edmondson ND, Talbot F, et al: Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridization. Br J Ophthalmol 2001;85:1440-1444. (Pubitemid 34032910)
23. Cook JR: Fluorescence in situ hybridization; in Tubbs RR, Stoler MH (eds): Cell and Tissue Based Molecular Pathology, ed 1. Philadelphia, Churchill Livingstone, 2009, vol 1, pp 104-113.
24. Harbour JW: Molecular prognostic testing and individualized patient care in uveal melanoma. Am J Ophthalmol 2009;148:823-829.
25. Onken MD, Worley LA, Person E, Char DH, Bowcock AM, et al: Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma. Clinic Cancer Res 2007;13:2923-2927. (Pubitemid 46849567)
26. Young TA, Burgess BL, Rao NP, Gorin MB, Straatsma BR: High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy. Mol Vis 2007;13:2328-2333.
27. Singh AD, Sisley K, Xu Y, Li J, Faber P, et al: Reduced expression of autotaxin predicts survival in uveal melanoma. Br J Ophthalmol 2007;91:1385-1392. (Pubitemid 47492881)
28. Tschentscher F, Hüsing J, Hölter T, Kruse E, Dresen IG, et al: Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res 2003;63:2578-2584. (Pubitemid 36608917)
29. Tschentscher F, Prescher G, Zeschnigk M, Horsthemke B, Lohmann DR: Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization. Cancer Genet Cytogenet 2000;122:13-17.
30. Onken MD, Worley LA, Ehlers JP, Harbour JW: Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004;64:7205-7209. (Pubitemid 39372052)
31. Onken MD, Lin AY, Worley LA, Folberg R, Harbour JW: Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas. Am J Ophthalmol 2005;140:748-749. (Pubitemid 41455330)
32. Petrausch U, Martus P, Tonnies H, Bechrakis NE, Lenze D, et al: Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases. Eye 2007;22:997-1007.
33. Van Gils W, Lodder EM, Mensink HW, Kiliç E, Naus NC, et al: Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis. Invest Ophthalmol Vis Sci 2008;49:4254-4262.
34. Onken MD, Worley LA, Davila RM, Char DH, Harbour JW: Prognostic testing in uveal melanoma by transcriptomic profiling of fine-needle biopsy specimens. J Mol Diagn 2006;8:567-573. (Pubitemid 44774155)
35. Onken MD, Worley LA, Tuscan MD, Harbour JW: An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn 2010;12:461-468.
36. Maat W, Jordanova ES, van Zelderen-Bhola SL, et al: The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies. Arch Pathol Lab Med 2007;131:91-96. (Pubitemid 46174141)
37. Schoenfield L, Pettay J, Tubbs RR, Singh AD: Variation of monosomy 3 status within uveal melanoma. Arch Pathol Lab Med 2009, 133:1219-1222.
38. Mensink HW, Vaarwater J, Kilic E, Naus NC, Mooy N, et al: Chromosome 3 intratumor heterogeneity in uveal melanoma. Invest Ophthalmol Vis Sci 2009;50:500-504.